This is a $2,010.06 firm fixed-price purchase order contract awarded by the Defense Department's Medical Supply Chain agency to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdoses, with a performance period ending on May 31, 2024. The Maclean Group holds several other significant federal contract...
This is a federal contract award from the Department of Defense's Medical Supply Chain organization to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The $1,005.03 firm fixed-price purchase order is for the delivery of naloxone hydrochloride, a critical medical product used to treat opioid overdoses. The contract has an ultimate completion date of May 16, 2025. The Maclean Group, an ISO 9001:2015 certified...
The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,005.03 firm fixed price purchase order to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The award is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose, and has a period of performance through March 13, 2025. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical...
This is a firm fixed price purchase order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract, valued at $2,010.06, is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has a performance period ending on May 10, 2024. The Maclean Group is an ISO 9001:2015 certified...
This federal contract award, valued at $2,010.06, was issued by the Medical Supply Chain division of the Department of Defense to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the purchase of 8510598440 - Naloxone Hydrochloride, a critical medication used to reverse opioid overdoses. The contract is a firm fixed-price purchase order with a completion date of May 13, 2024. The Maclean Group LLC is an...
This is a $2,010.06 firm fixed price purchase order contract awarded by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, a critical medication used to reverse opioid overdoses. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several...
This federal contract award, valued at $5,025.15, was issued by the Medical Supply Chain division of the Defense Department to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. This is a firm fixed price purchase order with a completion date of July 11, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical...
This is a firm fixed-price purchase order awarded by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, with a ceiling value of $1,005.03 and a performance period through May 20, 2025. The Maclean Group holds several significant federal contract vehicles, including a $2.63...
The U.S. government's Defense agency, specifically the Medical Supply Chain, has awarded a $4,020.12 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose, with a completion date of June 18, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale...
The U.S. government agency Medical Supply Chain has awarded a $1,005.03 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, a critical medical product used to treat opioid overdoses. This contract is not set aside for any specific business category. The Maclean Group is an ISO 9001:2015...